Also trades as: AZN.L (LSE) · $vol 541M · AZN.ST (STO) · $vol 91M · AZNCF (OTC) · $vol 31M · ZEG.DE (XETRA) · $vol 1M
AZN NYSE
AstraZeneca PLC
1W: +0.7%
1M: +2.3%
3M: -1.2%
YTD: -6.3%
1Y: +4.5%
3Y: +39.8%
5Y: +56.5%
$170.08
-1.98 (-1.15%)
Weekly Expected Move ±3.9%
$158
$165
$171
$178
$185
Credit Risk of going bust: lower than 80% of companies Debt: 10.9% of company value Bonds: $298.6M held by 249 funds, 47 bp over Treasuries → details ▾
If the stock fell to about $1.55 (down 99.1%), AstraZeneca PLC would be worth roughly what it owes.
Total debt $32.20B against a stock market value of $263.77B.
Distance to default 9.61 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.05B (short-term plus half of long-term), stock volatility 30.5%; Altman Z'' 1.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $32.20B against a stock market value of $263.77B.
Distance to default 9.61 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.05B (short-term plus half of long-term), stock volatility 30.5%; Altman Z'' 1.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$61B
Revenue
+8.6% YoY
$10B
Net Income
+25.9% YoY
$10B
Free Cash Flow
+12.1% YoY
83.6%
Gross Margin
20.6%
Op. Margin
16.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE22.0%
ROA9.2%
ROIC15.0%
Valuation
P/E25.4
P/B5.2
EV/EBITDA15.5
Leverage
Debt/Equity0.64
Current Ratio0.89
Interest Cov.8.3x
Quality Scores
Piotroski F9/9
Altman Z3.75
Beneish M-2.52